Literature DB >> 22942628

Liver abnormalities in cardiac diseases and heart failure.

Alicia M Alvarez1, Debabrata Mukherjee.   

Abstract

Heart failure (HF) is characterized by the inability of systemic perfusion to meet the body's metabolic demands and is usually caused by cardiac pump dysfunction and may occasionally present with symptoms of a noncardiac disorder such as hepatic dysfunction. The primary pathophysiology involved in hepatic dysfunction from HF is either passive congestion from increased filling pressures or low cardiac output and the consequences of impaired perfusion. Passive hepatic congestion due to increased central venous pressure may cause elevations of liver enzymes and both direct and indirect serum bilirubin. Impaired perfusion from decreased cardiac output may be associated with acute hepatocellular necrosis with marked elevations in serum aminotransferases. Cardiogenic ischemic hepatitis ("shock liver") may ensue following an episode of profound hypotension in patients with acute HF. We discuss pathophysiology and identification of liver abnormalities that are commonly seen in patients with HF.

Entities:  

Keywords:  Heart failure; cardiac output; cardiovascular disease; hepatic congestion; liver dysfunction; pulsatile liver; shock liver

Year:  2011        PMID: 22942628      PMCID: PMC3331650          DOI: 10.1055/s-0031-1284434

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  43 in total

1.  Heart rate is a marker of amiodarone mortality reduction in severe heart failure. The GESICA-GEMA Investigators. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina-Grupo de Estudios Multicéntricos en Argentina.

Authors:  D R Nul; H C Doval; H O Grancelli; S D Varini; S Soifer; S V Perrone; N Prieto; O Scapin
Journal:  J Am Coll Cardiol       Date:  1997-05       Impact factor: 24.094

2.  Constrictive pericarditis masquerading as Budd-Chiari syndrome.

Authors:  A Arora; N Tandon; M P Sharma; S K Acharya
Journal:  J Clin Gastroenterol       Date:  1991-04       Impact factor: 3.062

Review 3.  The liver in congestive heart failure: a review.

Authors:  G D Dunn; P Hayes; K J Breen; S Schenker
Journal:  Am J Med Sci       Date:  1973-03       Impact factor: 2.378

4.  Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study.

Authors:  R Zaman; D B Jack; M R Wilkins; M J Kendall
Journal:  Biopharm Drug Dispos       Date:  1985 Apr-Jun       Impact factor: 1.627

5.  Clinical experience with atenolol in patients with chronic liver disease.

Authors:  W Kirch; M Schäfer-Korting; E Mutschler; E E Ohnhaus; W Braun
Journal:  J Clin Pharmacol       Date:  1983-04       Impact factor: 3.126

6.  Chronic passive congestion of the liver in man. Electron microscopic study of cell atrophy and intralobular fibrosis.

Authors:  A P Safran; F Schaffner
Journal:  Am J Pathol       Date:  1967-03       Impact factor: 4.307

7.  Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury.

Authors:  W M Cassidy; T B Reynolds
Journal:  J Clin Gastroenterol       Date:  1994-09       Impact factor: 3.062

8.  Ischemic hepatitis due to obstructive sleep apnea.

Authors:  P Mathurin; F Durand; N Ganne; J L Mollo; D Lebrec; C Degott; S Erlinger; J P Benhamou; J Bernuau
Journal:  Gastroenterology       Date:  1995-11       Impact factor: 22.682

9.  Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA).

Authors:  J J Garguichevich; J L Ramos; A Gambarte; A Gentile; S Hauad; O Scapin; J Sirena; M Tibaldi; J Toplikar
Journal:  Am Heart J       Date:  1995-09       Impact factor: 4.749

10.  Morphologic features of hepatic injury in cardiac disease and shock.

Authors:  J H Lefkowitch; L Mendez
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

View more
  50 in total

Review 1.  Hepato-cardiac disorders.

Authors:  Yasser Mahrous Fouad; Reem Yehia
Journal:  World J Hepatol       Date:  2014-01-27

2.  Assessment of the effects of hepatic impairment and smoking on the pharmacokinetics of a single oral dose of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521).

Authors:  Reiner Frey; Corina Becker; Sigrun Unger; Anja Schmidt; Georg Wensing; Wolfgang Mück
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

3.  Interpretable Topic Features for Post-ICU Mortality Prediction.

Authors:  Yen-Fu Luo; Anna Rumshisky
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

Review 4.  Loop diuretics in chronic heart failure: how to manage congestion?

Authors:  Justas Simonavičius; Christian Knackstedt; Hans-Peter Brunner-La Rocca
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

Review 5.  Incorporating pharmacokinetic data into personalised prescribing for older people: challenges and opportunities.

Authors:  Arduino A Mangoni; Elzbieta A Jarmuzewska
Journal:  Eur Geriatr Med       Date:  2021-01-08       Impact factor: 1.710

6.  Pretransplant coagulopathy and in-hospital outcomes among heart transplant recipients: a propensity-matched nationwide inpatient sample study.

Authors:  Marjan Mujib; Neel Khanna; Nabila K Mazumder; Wilbert S Aronow; Dhaval Kolte; Sahil Khera; Chandrasekar Palaniswamy; Diwakar Jain; Gregg M Lanier; Sachin Sule; Ali Ahmed; Wayne C Levy; Sumanth D Prabhu; Howard A Cooper; Julio A Panza; Alan L Gass; Gregg C Fonarow
Journal:  Clin Cardiol       Date:  2015-02-13       Impact factor: 2.882

Review 7.  Congenital heart disease-associated liver disease: a narrative review.

Authors:  Florian P Reiter; Nino J Hadjamu; Nicole Nagdyman; Reinhart Zachoval; Julia Mayerle; Enrico N De Toni; Harald Kaemmerer; Gerald Denk
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

8.  FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patients.

Authors:  Kaku A So-Armah; Joseph K Lim; Vincent Lo Re; Janet P Tate; Chung-Chou H Chang; Adeel A Butt; Cynthia L Gibert; David Rimland; Vincent C Marconi; Matthew B Goetz; Maria C Rodriguez-Barradas; Matthew J Budoff; Hilary A Tindle; Jeffrey H Samet; Amy C Justice; Matthew S Freiberg
Journal:  Hepatology       Date:  2017-08-30       Impact factor: 17.425

9.  Early cytokine signatures of ischemia/reperfusion injury in human orthotopic liver transplantation.

Authors:  Rebecca A Sosa; Ali Zarrinpar; Maura Rossetti; Charles R Lassman; Bita V Naini; Nakul Datta; Ping Rao; Nicholas Harre; Ying Zheng; Roberto Spreafico; Alexander Hoffmann; Ronald W Busuttil; David W Gjertson; Yuan Zhai; Jerzy W Kupiec-Weglinski; Elaine F Reed
Journal:  JCI Insight       Date:  2016-12-08

Review 10.  Fructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease.

Authors:  Peter Mirtschink; Cholsoon Jang; Zoltan Arany; Wilhelm Krek
Journal:  Eur Heart J       Date:  2018-07-07       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.